BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| bifidobacterium bifidum {B. bifidum} - Bifidobacterium biavatii |
👶
Early life administration of Bifidobacterium bifidum BD-1 alleviates long-term colitis by remodeling the gut microbiota and promoting intestinal barrier development. Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 916824 Pub: 2022 Epub: 2022 Jul 22 Authors Peng C , Li J , Miao Z , Wang Y , Wu S , Wang Y , Wang S , Cheng R , He F , Shen X , Html Article Publication |
| bifidobacterium bifidum {B. bifidum} - Bifidobacterium biavatii |
👶
Effect of Probiotic Bifidobacterium bifidum TMC3115 Supplementation on Psychosocial Stress Using a Sub-Chronic and Mild Social Defeat Stress in Mice. Nutrients (Nutrients ) Vol: 14 Issue 5 Pages: Pub: 2022 Feb 24 Epub: 2022 Feb 24 Authors Yoda K , Harata G , Sato M , Miyazawa K , Ohsawa N , He F , Toyoda A , Html Article Publication |
| bifidobacterium bifidum {B. bifidum} - Bifidobacterium biavatii |
👶
[Bifidobacterium bifidum TMC3115 Promotes Early Life Intestinal Microbiota Building to Alleviate Symptoms of Inflammatory Bowel Disease]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition (Sichuan Da Xue Xue Bao Yi Xue Ban ) Vol: 53 Issue 5 Pages: 834-841 Pub: 2022 Sep Epub: Authors Peng CR , Wang YM , Wang SL , Wu SM , Li JX , Cheng RY , He F , Shen X , Html Article Publication |
| bifidobacterium bifidum {B. bifidum} - Bifidobacterium biavatii |
👶
Bifidobacterium bifidum CCFM1163 Alleviated Cathartic Colon by Regulating the Intestinal Barrier and Restoring Enteric Nerves. Nutrients (Nutrients ) Vol: 15 Issue 5 Pages: Pub: 2023 Feb 24 Epub: 2023 Feb 24 Authors Tang N , Yu Q , Mei C , Wang J , Wang L , Wang G , Zhao J , Chen W , Html Article Publication |
| bifidobacterium bifidum {B. bifidum} - Bifidobacterium biavatii |
👶
[Effect of probiotic product containing bifidobacteria and biogel from brown algae on the intestinal microflora and parameters of innate immunity in mice with experimental drug dysbacteriosis]. Voprosy pitaniia (Vopr Pitan ) Vol: 84 Issue 1 Pages: 73-9 Pub: 2015 Epub: Authors Kuznetsova TA , Makarenkova ID , Koneva EL , Aminina NM , Yakush EV , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
